Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS)

被引:51
作者
Hong, HX [1 ]
Dragan, Y
Epstein, J
Teitel, C
Chen, BZ
Xie, Q
Fang, H
Shi, LM
Perkins, R
Tong, WD
机构
[1] US FDA, Div Bioinformat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[2] US FDA, Div Syst Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[3] Univ Arkansas Med Sci, Myleoma Inst Res & Therapy, Arkansas Canc Res Ctr, Little Rock, AR 72205 USA
[4] US FDA, Div Mol Epidemiol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
关键词
D O I
10.1186/1471-2105-6-S2-S5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Proteomic profiling of complex biological mixtures by the ProteinChip technology of surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry ( MS) is one of the most promising approaches in toxicological, biological, and clinic research. The reliable identification of protein expression patterns and associated protein biomarkers that differentiate disease from health or that distinguish different stages of a disease depends on developing methods for assessing the quality of SELDI-TOF mass spectra. The use of SELDI data for biomarker identification requires application of rigorous procedures to detect and discard low quality spectra prior to data analysis. Results: The systematic variability from plates, chips, and spot positions in SELDI experiments was evaluated using biological and technical replicates. Systematic biases on plates, chips, and spots were not found. The reproducibility of SELDI experiments was demonstrated by examining the resulting low coefficient of variances of five peaks presented in all 144 spectra from quality control samples that were loaded randomly on different spots in the chips of six bioprocessor plates. We developed a method to detect and discard low quality spectra prior to proteomic profiling data analysis, which uses a correlation matrix to measure the similarities among SELDI mass spectra obtained from similar biological samples. Application of the correlation matrix to our SELDI data for liver cancer and liver toxicity study and myeloma-associated lytic bone disease study confirmed this approach as an efficient and reliable method for detecting low quality spectra. Conclusion: This report provides evidence that systematic variability between plates, chips, and spots on which the samples were assayed using SELDI based proteomic procedures did not exist. The reproducibility of experiments in our studies was demonstrated to be acceptable and the profiling data for subsequent data analysis are reliable. Correlation matrix was developed as a quality control tool to detect and discard low quality spectra prior to data analysis. It proved to be a reliable method to measure the similarities among SELDI mass spectra and can be used for quality control to decrease noise in proteomic profiling data prior to data analysis.
引用
收藏
页数:11
相关论文
共 25 条
[1]   Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization [J].
Coombes, KR ;
Fritsche, HA ;
Clarke, C ;
Chen, JN ;
Baggerly, KA ;
Morris, JS ;
Xiao, LC ;
Hung, MC ;
Kuerer, HM .
CLINICAL CHEMISTRY, 2003, 49 (10) :1615-1623
[2]  
Dare TO, 2002, ELECTROPHORESIS, V23, P3241, DOI 10.1002/1522-2683(200209)23:18<3241::AID-ELPS3241>3.0.CO
[3]  
2-D
[4]  
Drake RR, 2004, BIOPROCESSING J, V3, P45
[5]   Identification of pleiotrophin in conditioned medium secreted from neural stem cells by SELDI-TOF and SELDI-tandem mass spectrometry [J].
Furuta, M ;
Shiraishi, T ;
Okamoto, H ;
Mineta, T ;
Tabuchi, K ;
Shiwa, M .
DEVELOPMENTAL BRAIN RESEARCH, 2004, 152 (02) :189-197
[6]  
Gilbert Kate, 2004, Methods Mol Biol, V264, P259
[7]   Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers [J].
Gravett, MG ;
Novy, MJ ;
Rosenfeld, RG ;
Reddy, AP ;
Jacob, T ;
Turner, M ;
McCormack, A ;
Lapidus, JA ;
Hitti, J ;
Eschenbach, DA ;
Roberts, CT ;
Nagalla, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (04) :462-469
[8]   Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF [J].
Gretzer, MB ;
Chan, DW ;
van Rootselaar, CL ;
Rosenzweig, JM ;
Dalrymple, S ;
Mangold, LA ;
Partin, AW ;
Veltri, RW .
PROSTATE, 2004, 60 (04) :325-331
[9]   The Early Detection Research Network surface-enhanced laser desorption and ionization prostate cancer detection study: a study in biomarker validation in genitourinary oncology [J].
Grizzle, WE ;
Semmes, OJ ;
Basler, J ;
Izbicka, E ;
Feng, ZD ;
Kagan, J ;
Adam, BL ;
Troyer, D ;
Srivastava, S ;
Thornquist, M ;
Zhang, Z ;
Thompson, IM .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) :337-343
[10]  
Jolliffe IT, 1986, PRINCIPAL COMPONENT